Jin Wu Financial News | Dr. Ping An (01833) announced that for the year ended December 31, 2023, losses attributable to company owners recorded a loss of 323 million yuan (RMB, same below), a year-on-year decrease of 49.28%. The basic loss per share was 0.3 yuan, with no dividend.
During the period, revenue was recorded at $4.674 billion, a year-on-year decrease of 24.68%. The company recorded F-side strategic business revenue (that is, F-side medical and health service revenue, same) of 2.205 billion yuan, up 14.8% year on year, up 4.5% in the second half of the year; recorded B-side strategic business revenue (referring to enterprise health business, B-side healthcare services, same later) of 1,079 million yuan, up 81.2% year on year, and 40.1% month-on-month increase in the second half of the year. Basic adjustments to the company's low strategic collaboration business were completed.
During the period, gross profit was recorded at 1,508 billion yuan, a year-on-year decrease of 10.79%. The completion of basic adjustments to the company's low strategic synergy business and the continuous optimization of the business structure promoted a further increase in the company's gross margin level. In 2023, the company's gross margin increased 5.4 percentage points year-on-year to 32.3%.
Looking at revenue in detail, the revenue of the medical services sector was 2,075 billion yuan, down 19.9% year on year. Mainly due to the company's focus on resource development, low strategic synergy revenue from medical services declined, and further continued to deepen comprehensive financial business collaboration with Ping An Group to provide rich medical services such as chronic disease management, co-diagnosis with famous doctors, and medical assistance. The gross margin of the medical services sector was 40.0%, an increase of 4.9 percentage points over the previous year.
The revenue of the health services sector was 2,598 billion yuan, a year-on-year decrease of 28.1%. This is mainly due to a decrease in revenue from some physical sales businesses that are less related to managed medical strategies and have lower profitability. The gross margin of the health services sector was 26.1%, an increase of 5.0 percentage points over the previous year.